Biotech entity
All 1 tracked stories fall under one category: pharma. Of the tracked stories, 1 of 1 also mention AlpE, the most common co-covered peer. Each carries 2 original sources on average. We currently track 1 Biotech story that mention BV300, all published on March 18, 2026.
Last mentioned: Mar 18, 2026
Entity pulse
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
All 1 tracked stories fall under one category: pharma. Of the tracked stories, 1 of 1 also mention AlpE, the most common co-covered peer. Each carries 2 original sources on average. We currently track 1 Biotech story that mention BV300, all published on March 18, 2026.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 18 Biotech stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering BV300. Shared-story counts are live from our verified record — not editorial picks.
2025 Earnings Release
BioVersys officially reports 2025 financial results and corporate highlights.
AlpE Phase 2b Milestone
First patient dosed in the Phase 2b clinical trial of AlpE for pulmonary tuberculosis.
Reporting Announcement
Company announces date for full-year 2025 results and business update.
Fiscal Year End
BioVersys concludes its 2025 fiscal year with key pipeline advancements.
BioVersys AG reported its full-year 2025 financial results, highlighting the successful transition of its lead candidate AlpE into Phase 2b clinical trials for pulmonary tuberculosis. The company's progress underscores its leadership in the antimicrobial resistance (AMR) space as it moves toward late-stage clinical validation.
BV300 is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
